Monday, April 6, 2009

Bioject Announces FDA Market Clearance for the Zetajet Needle-Free Injection Therapy System

Apr 6, 2009 -Bioject Medical Technologies Inc., a leading developer of needle-free injection therapy systems, today announced that the U.S. FDA has granted market clearance for the Zetajet™ Needle-Free Injection Therapy System.

The details can be read here.

No comments: